Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to an immune attack on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to an immune attack on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Immune system changes may contribute to female pattern hair loss.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.